Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCvc Ig Eur Regulatory News (CVCE)

Share Price Information for Cvc Ig Eur (CVCE)

Share Price is delayed by 15 minutes
Get Live Data
1.055    0.00 (0.00%)
Bid:
1.05
Ask:
1.07
Spread: 0.02 (1.905%)
Market Cap: €292.81m
CVCE Live PriceLast checked at - London Stock Exchange

Intraday Cvc Ig Eur Share Chart

Total Voting Rights

15 May 2026 14:44

RNS Number : 5793E
CVC Income & Growth Limited
15 May 2026
 

15 May 2026

 

CVC Income & Growth Limited

(the Company)

 

Total Voting Rights

 

 

Further to the completion of the March 2026 Contractual Semi-Annual Tender today and pursuant to Rule 5.6.1A(1) of the FCA's Disclosure Guidance and Transparency Rules, the Company notifies the market of the following:

 

As at 12pm on 15 May 2026, the Company's issued share capital (excluding treasury shares) consisted of:

 

· 193,255,993 ordinary Sterling shares of no par value; and

· 83,790,791 ordinary Euro shares of no par value.

 

Each ordinary Sterling share carries the right to 1.17 votes, and each ordinary Euro share carries the right to 1 vote.

 

The total number of voting rights of the ordinary Sterling shares of no par value is 226,109,511 and of the ordinary Euro shares of no par value is 83,790,791.

 

The total number of voting rights in the Company is therefore 309,900,302.

 

The Company holds the following ordinary shares in treasury:

 

· 178,753,766 ordinary Sterling shares of no par value (non-voting); and

· 58,309,884 ordinary Euro shares of no par value (non-voting).

 

The above figure, 309,900,302, may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries:

BNP Paribas S.A., Jersey Branch

Company Secretary

 cvccpeolcosec@bnpparibas.com

 

 

 

Cadarn Capital

Distribution and Investor Relations

 

Telephone: +44 20 7019 9042

 info@cadarncapital.com

 

 

Winterflood Securities

Broker

 

Telephone: +44 0203 100 0000

 

 Neil Morgan - Corporate Finance

 Innes Urquhart - Corporate Sales

 Darren Willis - Corporate Sales

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRGPUPCAUPQGWA
Date   Source Headline
30th Apr 20257:00 amRNSDividend Declaration
29th Apr 20254:50 pmRNSResult of AGM
28th Apr 20254:03 pmRNSIssue of Equity
25th Apr 20259:35 amRNSNet Asset Value Weekly to 17 Apr 2025
24th Apr 20255:49 pmRNSIssue of Equity
23rd Apr 20253:27 pmRNSMONTHLY REPORT
23rd Apr 202511:50 amRNSNet Asset Value Weekly to 11 Apr 2025
22nd Apr 202511:37 amRNSMarch 2025 Tender Price
11th Apr 20254:49 pmRNSNotice of 2025 Annual General Meeting
10th Apr 20254:05 pmRNSNet Asset Value Weekly to 04 Apr 2025
7th Apr 20253:53 pmRNSDirector/PDMR Shareholding
7th Apr 202511:42 amRNSDirector/PDMR Shareholding
2nd Apr 20256:10 pmRNSNet Asset Value Weekly to 28 Mar 2025
1st Apr 202511:34 amRNSTotal Voting Rights
27th Mar 20253:12 pmRNSIssue of Equity
27th Mar 20252:45 pmRNSNet Asset Value Weekly to 21 Mar 2025
27th Mar 20257:00 amRNS2024 Annual Report and Financial Statements
25th Mar 20254:06 pmRNSIssue of Equity
20th Mar 20253:30 pmRNSNet Asset Value Weekly to 14 Mar 2025
19th Mar 202511:17 amRNSMONTHLY REPORT
19th Mar 202511:07 amRNSIssue of Equity
14th Mar 202510:16 amRNSNet Asset Value Month End 28 Feb 2025
13th Mar 20251:50 pmRNSNet Asset Value Weekly to 07 Mar 2025
12th Mar 20253:13 pmRNSIssue of Equity
10th Mar 202512:11 pmRNSIssue of Equity
6th Mar 20254:35 pmRNSNet Asset Value Weekly to 28 Feb 2025
6th Mar 202510:43 amRNSRESULTS OF PLACINGS FOR MARCH 2025 TENDER
3rd Mar 20254:55 pmRNSTotal Voting Rights
3rd Mar 20254:06 pmRNSIssue of Equity
27th Feb 202512:35 pmRNSNet Asset Value Weekly to 21 Feb 2025
27th Feb 202510:55 amRNSIssue of Equity
26th Feb 20253:36 pmRNSIssue of Equity
26th Feb 20259:37 amRNSMONTHLY REPORT
21st Feb 20255:09 pmRNSNet Asset Value Weekly to 14 Feb 2025
18th Feb 20259:01 amRNSNet Asset Value Month End 31 Jan 2025
14th Feb 20255:27 pmRNSResult of March 25 Tender Process (Replacement)
14th Feb 20252:38 pmRNSResult of March 2025 Semi-Annual Tender Process
14th Feb 20251:50 pmRNSNet Asset Value Weekly to 07 Feb 2025
14th Feb 202510:29 amRNSIssue of Equity
13th Feb 20254:58 pmRNSIssue of Equity
11th Feb 202511:54 amRNSDirector/PDMR Shareholding
11th Feb 20259:47 amRNSHolding(s) in Company
6th Feb 20255:10 pmRNSNet Asset Value Weekly to 31 Jan 2025
6th Feb 20251:32 pmRNSIssue of Equity
5th Feb 20254:36 pmRNSIssue of Equity
5th Feb 20253:58 pmRNSDirector/PDMR Shareholding
4th Feb 20253:10 pmRNSHolding(s) in Company
4th Feb 202510:01 amRNSHolding(s) in Company
3rd Feb 20254:58 pmRNSTotal Voting Rights
31st Jan 202510:11 amRNSNet Asset Value Weekly to 24 Jan 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.